IDROFOS 150MG TABLET

IDROFOS 150MG TABLET belongs to a group of medications called 'bisphosphonates' used to prevent post-menopausal osteoporosis. It is indicated in adults for the prevention of skeletal events such as pathological fractures and bone complications requiring surgery or radiotherapy in patients with bone metastases or breast cancer.

IDROFOS 150MG TABLET contains 'Ibandronic acid', which suppresses the activity of osteoclasts and makes the bone stronger. It lowers the risk of getting a fracture and reduces pain in the bones. IDROFOS 150MG TABLET may reverse bone loss by increasing bone mass and stopping more bone loss.

Take IDROFOS 150MG TABLET exactly as prescribed by the doctor. In some cases, IDROFOS 150MG TABLET may cause side effects like heartburn, muscle pain, indigestion, headache, and nausea. Most of these side effects of IDROFOS 150MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, consult your doctor. 

Do not lie down for 60 minutes after taking IDROFOS 150MG TABLET, and avoid eating your first food of the day for at least 60 minutes after taking IDROFOS 150MG TABLET.Consult your doctor if you are pregnant or breastfeeding. IDROFOS 150MG TABLET is not recommended for children below 18 years as safety and effectiveness have not been established. 

IDROFOS 150MG TABLET belongs to a group of medications called 'bisphosphonates' used to prevent post-menopausal osteoporosis. It is indicated in adults for the prevention of skeletal events such as pathological fractures and bone complications requiring surgery or radiotherapy in patients with bone metastases or breast cancer. IDROFOS 150MG TABLET may also be used to lower hypercalcemia (higher levels of calcium in the blood). IDROFOS 150MG TABLET contains 'Ibandronic acid', which suppresses the activity of osteoclasts and makes the bone stronger. It lowers the risk of getting a fracture and reduces pain in the bones. IDROFOS 150MG TABLET may reverse bone loss by increasing bone mass and stopping more bone loss.

• Back pain
• Heartburn
• Abdominal pain
• Diarrhoea
• Headache
• Myalgia (muscle pain)
• Indigestion

Do not take IDROFOS 150MG TABLET if you are allergic to any of its components, have problems with the oesophagus, cannot sit or stand upright for at least 60 minutes, or have low calcium levels in the blood. Inform your doctor if you have problems with swallowing, stomach or digestive problems, malabsorption syndrome, kidney or liver problems, or if you plan to have teeth removal or dental surgery. Consult your doctor if you are pregnant or breastfeeding. IDROFOS 150MG TABLET may cause problems with the oesophagus, low blood calcium levels, bone, joint, or muscle pain, osteonecrosis (severe jaw bone problems), and unusual thigh bone fractures. Keep your doctor informed about your health condition and medications to rule out any interactions/side effects.

Drug-Drug interaction: IDROFOS 150MG TABLET may interact with antacids, pain killers (aspirin), and NSAIDs.

Drug-Food interaction: Do not take IDROFOS 150MG TABLET with mineral water, coffee, tea, soda, or juice.

Drug-Disease interaction: Inform your doctor if you have problems with the oesophagus, hypocalcemia, or severe renal problems.

• ASPIRIN

• Eat a balanced diet rich in calcium and vitamin D.
• Avoid smoking and heavy alcohol consumption.
• Do walking, weight-bearing, and strength-training exercises.
• Include fresh fruits, vegetables, and whole grains in your diet.
• Limit your intake of caffeine.

• If you miss a dose of IDROFOS 150MG TABLET, do not take the missed dose later in the day. Consult your doctor for instructions.
• Maintain a gap of one hour between IDROFOS 150MG TABLET and other medicines such as calcium supplements, indigestion tablets, or vitamins. However, you are advised to consult your doctor before taking other medicines with IDROFOS 150MG TABLET.

Osteoporosis: It is a bone disease that causes bone weakness and thinning by lowering bone density. Bones become weaker and more prone to breaking as their density decreases. Women are more likely than men to develop osteoporosis after menopause because their ovaries stop producing oestrogen (a female hormone) needed to keep bones healthy. Bone loss occurs after menopause, weakening bones and making them more likely to break. Back pain caused by a fractured or collapsed vertebra, gradual loss of height, a stooped posture, and bones that break much more quickly than expected are all signs and symptoms.